Investment Fund

129 Total Holdings:
As of 9/30/24
All Holdings: 1 - 15 of 129
Security Name Asset Type Shares or
Principal Amount
Market Value Percent of
Net Assets
descending arrow
Capital Group Central Cash Fund Short Term 1,127,835 $112,806,029.00 5.22%
Novo Nordisk AS, Class B Equity 629,450 $74,950,669.00 3.47%
SAP SE Equity 289,144 $65,682,331.00 3.04%
Safran SA Equity 261,721 $61,753,284.00 2.86%
AstraZeneca PLC Equity 347,911 $54,192,303.00 2.51%
ASML Holding NV Equity 60,240 $50,219,057.00 2.33%
TotalEnergies SE Equity 749,620 $48,586,844.00 2.25%
London Stock Exchange Group PLC Equity 348,689 $47,676,588.00 2.21%
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) Equity 254,562 $44,209,783.00 2.05%
Rolls-Royce Holdings PLC Equity 5,102,346 $36,034,333.00 1.67%
L'Oreal SA, non-registered shares Equity 78,294 $35,099,488.00 1.63%
EssilorLuxottica SA Equity 147,868 $35,038,841.00 1.62%
Sika AG Equity 102,764 $34,093,909.00 1.58%
Amadeus IT Group SA, Class A, non-registered shares Equity 468,188 $33,792,926.00 1.56%
Keyence Corp. Equity 69,020 $33,036,544.00 1.53%
All Holdings: 1 - 15 of 129